Market Size of Microcarrier Industry
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 2.03 Billion |
| Market Size (2029) | USD 2.70 Billion |
| CAGR (2024 - 2029) | 5.82 % |
| Fastest Growing Market | North America |
| Largest Market | Asia Pacific |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Microcarrier Market Analysis
The Microcarrier Market size is estimated at USD 2.03 billion in 2024, and is expected to reach USD 2.70 billion by 2029, growing at a CAGR of 5.82% during the forecast period (2024-2029).
The microcarrier market is majorly driven by factors such as rising demand for cell-based vaccines and therapeutics, the rapid growth of biologics and biosimilar industry, and increasing R&D and availability of funding for cell therapy research.
Many of the current biologics in the pipeline are targeting the indications, which are small-molecule dominated and have a large patient pool. This represents that in the forecast period the trend of biologics could enter several of the non-traditional biologic disease areas, which could benefit from the increased therapeutic efficacy. Furthermore, this is also providing the room to the biosimilar market to grow.
In terms of medical efficacy, therapeutic spread, and population access biopharmaceuticals have vast potential, and much of this potential is still untapped. This potential can gradually be realized as manufacturing technologies, such as microcarrier based synthesis make progress, which may lead to commercialization of more effective therapies, increased manufacturing efficacy, and reduced therapy costs. Hence, owing to such rapid growth of the biologics and biosimilar industry, the market is positively affected.
